La tétracycline, connue sous le nom commercial Sumycin, agit en bloquant la fixation de l’ARNt sur la sous-unité 30S ribosomale, interrompant l’élongation de la chaîne protéique bactérienne. Ce mécanisme confère une activité sur un spectre large, incluant bactéries Gram positives, Gram négatives, rickettsies et spirochètes. Sa biodisponibilité digestive varie selon la prise alimentaire et les interactions avec les ions divalents comme calcium et magnésium. Sa diffusion tissulaire est importante, notamment dans les voies respiratoires et génito-urinaires. L’élimination se fait par voie rénale et biliaire. Les effets indésirables incluent photosensibilisation, troubles digestifs et coloration dentaire en cas d’administration précoce. Les guides thérapeutiques mentionnent sumycin prix, en soulignant la nécessité de restreindre son utilisation afin de limiter les résistances acquises.

Poconoambulatorysurgerycenter.net

Patient Name: ____________________________________________ Surgery Date: ____________________________________________ Operative Procedure: ______________________________________ ICD 9 Diagnostic Code: ____________________________________ Medical Clearance?  No  Yes, with __________________
PRE SURGICAL TESTING: MUST BE COMPLETED a minimum of 7-10 days before scheduled surgery date.
Form to be completed by surgeon. Please check all categories below which apply to patient.
DISEASE PROCESS MODIFIERS: Prior EKG over age 40 good for 3 months

 History of Diabetes: (FBS, POTASSIUM, EKG) 250.00
HISTORY OF CARDIAC DISEASE: Prior EKG good for 6 mos., diabetic patient 3 months

 Coronary Artery Disease: (CBC, CREATININE, POTASSIUM, EKG) 414.00  Hypertension: (CBC, CREATININE,
POTASSIUM, EKG) 401.9
 Renal: (CBC, CREATININE, POTASSIUM, EKG) 404.00  Angina: (CBC, CREATININE, POTASSIUM,
EKG) 413.9
 Myocardial Infarction: (CBC, CREATININE, POTASSIUM, EKG) 412  Diuretics: (CBC, CREATININE, POTASSIUM,
EKG) 276.0
HISTORY OF PULMONARY DISEASE: Prior EKG good for 6 mos., diabetic patient 3 months

 COPD: (POTASSIUM, EKG, CXR) 491.21  CHF: (POTASSIUM, EKG, CXR) 428.0
 LVF w/ pulmonary edema: (POTASSIUM EKG, CXR) 428.1  Emphysema: (POTASSIUM, EKG, CXR) 491.20
 Bronchitis: (POTASSIUM, EKG, CXR) 491.21  Asthma: If acute at PSS (POTASSIUM, EKG, CXR) 415.19
HISTORY OF LIVER DISEASE:
 Chronic, long term : (CBC, CREATININE, LFT, PT, PTT) 573.9  ETOH Abuse: (CBC, CREATININE, LFT, PT, PTT) 571.3
 Hepatitis: (CBC, CREATININE, LFT, PT, PTT) 573.3  Liver failure: (CBC, CREATININE, LFT, PT, PTT) 571.9
CATARACT CASES: If MAC: General Anes or non-cataract ophthalmology cases, default to disease process modifiers
 Diabetic: (FBS, POTASSIUM) 250.00  Renal History: (POTASSIUM) 404.00
 Cardiac History: (POTASSIUM) 414.00

OTHER FACTORS:
 Known Bleeding Disorder: (CBC, PT, PTT, BLEEDING TIME) 286.9
 Leukemia: (CBC, PT, PTT) 208.90
 Cancer: (code specific): (CBC) ____________
 All Menstr. Females, all GYN procedures: (BHCG) V72.40
(H&H) V78.0
MEDICATION MODIFIERS:
 Coumadin: (PT/INR) 286.9
 Digoxin: (CREATININE, POTASSIUM, DIGOXIN LEVEL) E942.1
 Steroids:

Other: ____________________________________________
Copies to: _________________________________________
Surgeon Signature: _________________________________
DEAR PATIENT: Please plan to spend about 45 minutes for your pre-operative visit. Screenings are done daily Monday through Friday
between the hours of 9:00 a.m. and 2:00 p.m. We welcome the opportunity to participate in your medical care. We depend on your
surgeon to evaluate your health and order the appropriate studies. We depend on YOU to provide accurate health screening information on
this form. PLEASE COMPLETE THE ATTACHED SURVEY BEFORE YOU ARRIVE. The Staff of Pocono Ambulatory Surgery
Center.
ASC forms Pre OP Labs, jm 06/99,7/99,3/00,9/01,5/02,3/03,9/04,6/05,1/06,4/07,5/07, 05/08, 11/09, 06/11Right Protected

Source: http://www.poconoambulatorysurgerycenter.net/Portals/0/documents/PRE_SURGICAL_TESTING.pdf

Precedent document

CHEMICALS AND LIFESCIENCE Winter 2006 QUARTERLY The Intellectual Property Group Introduction This quarterly newsletter from the Intellectual Property (“IP”) Group at Walker Morris intends to keep the IP Group’s clients and friends updated on some key developments in the legal environment affecting chemicals, pharmaceuticals, biotechnology and medical devices bu

precisionpharma.com

Javelin Pharmaceuticals Signs Commercial Supply Agreement with Precision Pharma Services New York-Based Contract Manufacturer to Supply Dyloject(TM) for Launch in Europe CAMBRIDGE, Mass., Feb 26, 2007 (BUSINESS WIRE) -- Javelin Pharmaceuticals, Inc. (AMEX: JAV), a leading developer of novel products for pain control, today announced it has signed a Commercial Supply Agreement with Precis

Copyright ©2018 Sedative Dosing Pdf